Paratek Has Based

Paratek is a stock I found while looking for pure plays on reshoring of U.S. drug manufacturing. I was looking for companies making precursors for drugs and in my search, I came across this company that manufactures antibiotics domestically. I bought it simply for the story and a nice chart, and it turned into a great investment thus far. They were working on a new antibiotics for community-acquired bacterial pneumonia and acute baceterial skin infections. The FDA recently approved its new antibiotic NUZYRA for oral dosing. After $10 per share falls, the next major resistance is around $13, the downward sloping long-term resistance (blue).